Lisata Therapeutics LSTA
NASDAQ LSTA
$1.05 +0.01 (+0.96%)
As of: Oct 21, 2026 · 3:58 PM EDT

Lisata Therapeutics (LSTA) Current Deferred Tax Assets (2011 - 2012)

Updated

Lisata Therapeutics (LSTA) posted Current Deferred Tax Assets of $628,499 for Q1 2012, up 35.5% from the prior quarter.

Analysis

Lisata Therapeutics (LSTA) Current Deferred Tax Assets (2011 - 2012) Analysis & Trends

At the end of FY2011, Lisata Therapeutics' Current Deferred Tax Assets came in at $463,689.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Lisata Therapeutics 9.47 Mn -49.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 628,499.00
Dec 31, 2011 463,689.00
Sep 30, 2011 621,105.00
API Access

Lisata Therapeutics Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=LSTA&period=max&api_key=YOUR_API_KEY